Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool

The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fatemeh Khatami, Mandana Hasanzad
Formato: article
Lenguaje:EN
Publicado: Urology Research Center 2020
Materias:
Acceso en línea:https://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares